Metastatic Endometrioid Adenocarcinoma
3 clinical trials · Condition
◉ Watch Metastatic Endometrioid Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer (NCT04498520) | Pamela Munster | 2021-03-31 |
| Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer (NCT02728258) | NRG Oncology | 2016-09-16 |
| Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer (NCT01935934) | National Cancer Institute (NCI) | 2013-05-08 |
Track Metastatic Endometrioid Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.